• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成熟的 CD40L RNA 电穿孔树突状细胞的效力与体外跟踪多功能 CD8(+)/CD28(+)细胞毒性 T 细胞反应相关,可通过检测 IL-12 的分泌情况来评估。

Potency of mature CD40L RNA electroporated dendritic cells correlates with IL-12 secretion by tracking multifunctional CD8(+)/CD28(+) cytotoxic T-cell responses in vitro.

机构信息

Research Department, Argos Therapeutics, Inc, Durham, NC 27704, USA.

出版信息

J Immunother. 2011 Jan;34(1):45-57. doi: 10.1097/CJI.0b013e3181fb651a.

DOI:10.1097/CJI.0b013e3181fb651a
PMID:21150712
Abstract

Electroporation of mature dendritic cells (DC) with RNA-encoding CD40L greatly enhances the production of interleukin (IL)-12, a proinflammatory cytokine necessary for the induction of T-cell immunity. Results presented herein reveal a correlation between the priming of CD28(+) antigen-reactive effector memory cytotoxic T lymphocytes (CTL) displaying 3 or 4 simultaneous effector functions and the quantity of IL-12 produced by postmaturation electroporation-CD40L DC. By using multiparameter flow cytometry, the quantities of IL-12 needed to prime naive antigen-reactive T cells to simultaneously produce interferon-γ and tumor necrosis factor-α in the presence or absence of IL-2 secretion in conjunction with lytic activity defined by CD107a expression can be used to determine the overall potency of a DC product. In the presence of IL-12, CTL differentiation toward lytic function is not accompanied by a reduction in the secretion of interferon-γ and tumor necrosis factor-α. Therefore, by measuring the availability of IL-12 one can predict the potency of a DC immunotherapeutics in relation to its ability to drive distinct effector memory CTL subsets with multifunctional activities.

摘要

用电穿孔法将编码 CD40L 的 RNA 转染成熟树突状细胞 (DC) 可极大地增强白细胞介素 (IL)-12 的产生,IL-12 是诱导 T 细胞免疫所必需的促炎细胞因子。本文介绍的结果表明,CD28(+)抗原反应性效应记忆细胞毒性 T 淋巴细胞 (CTL) 的激活与电穿孔-CD40L DC 后产生的 IL-12 数量之间存在相关性,这些 CTL 同时具有 3 种或 4 种效应功能。通过使用多参数流式细胞术,可以确定产生 IL-12 的数量,以在存在或不存在 IL-2 分泌的情况下,将初始抗原反应性 T 细胞同时诱导产生干扰素-γ 和肿瘤坏死因子-α,同时通过 CD107a 表达定义溶细胞活性,从而确定 DC 产品的总体效力。在 IL-12 的存在下,CTL 向溶细胞功能的分化不会伴随着干扰素-γ 和肿瘤坏死因子-α分泌的减少。因此,通过测量 IL-12 的可用性,可以预测 DC 免疫疗法的效力与其驱动具有多功能活性的不同效应记忆 CTL 亚群的能力之间的关系。

相似文献

1
Potency of mature CD40L RNA electroporated dendritic cells correlates with IL-12 secretion by tracking multifunctional CD8(+)/CD28(+) cytotoxic T-cell responses in vitro.成熟的 CD40L RNA 电穿孔树突状细胞的效力与体外跟踪多功能 CD8(+)/CD28(+)细胞毒性 T 细胞反应相关,可通过检测 IL-12 的分泌情况来评估。
J Immunother. 2011 Jan;34(1):45-57. doi: 10.1097/CJI.0b013e3181fb651a.
2
Cytokine maturation followed by CD40L mRNA electroporation results in a clinically relevant dendritic cell product capable of inducing a potent proinflammatory CTL response.细胞因子成熟后进行CD40L mRNA电穿孔,可产生一种具有临床相关性的树突状细胞产物,能够诱导强烈的促炎性细胞毒性T淋巴细胞反应。
J Immunother. 2008 Oct;31(8):731-41. doi: 10.1097/CJI.0b013e318183db02.
3
Priming of a novel subset of CD28+ rapidly expanding high-avidity effector memory CTL by post maturation electroporation-CD40L dendritic cells is IL-12 dependent.通过成熟后电穿孔-CD40L树突状细胞对新型CD28 +快速扩增的高亲和力效应记忆性细胞毒性T淋巴细胞亚群进行启动是依赖白细胞介素-12的。
J Immunol. 2008 Oct 15;181(8):5296-305. doi: 10.4049/jimmunol.181.8.5296.
4
Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.通过腺病毒介导的hCD40L基因与γ干扰素共转染,生成同时分泌白细胞介素-12并具有迁移能力的人树突状细胞。
J Immunother. 2009 Jun;32(5):524-38. doi: 10.1097/CJI.0b013e3181a28422.
5
Dendritic cell secretion of IL-15 is induced by recombinant huCD40LT and augments the stimulation of antigen-specific cytolytic T cells.重组人CD40配体可诱导树突状细胞分泌白细胞介素-15,并增强对抗原特异性细胞毒性T细胞的刺激。
Cell Immunol. 1999 Apr 10;193(1):48-58. doi: 10.1006/cimm.1999.1469.
6
Autogeneic rna-electroporated CD40-ligand activated b-cells from hepatocellular carcinoma patients induce CD8+ T-cell responses ex vivo.来自肝细胞癌患者的自体RNA电穿孔CD40配体激活的B细胞在体外诱导CD8 + T细胞反应。
Exp Oncol. 2007 Jun;29(2):137-43.
7
In vivo depletion of CD4+CD25+ regulatory T cells enhances the antigen-specific primary and memory CTL response elicited by mature mRNA-electroporated dendritic cells.体内清除CD4+CD25+调节性T细胞可增强成熟mRNA电穿孔树突状细胞引发的抗原特异性初始和记忆性CTL反应。
Mol Ther. 2005 Nov;12(5):922-32. doi: 10.1016/j.ymthe.2005.02.029.
8
CD40 signalling induces IL-10-producing, tolerogenic dendritic cells.CD40 信号诱导产生 IL-10 分泌的、具有免疫耐受原性的树突状细胞。
Exp Dermatol. 2010 Jan;19(1):44-53. doi: 10.1111/j.1600-0625.2009.00975.x. Epub 2009 Nov 2.
9
Proinflammatory cytokines and CD40 ligand enhance cross-presentation and cross-priming capability of human dendritic cells internalizing apoptotic cancer cells.促炎细胞因子和CD40配体可增强内化凋亡癌细胞的人树突状细胞的交叉呈递和交叉启动能力。
J Immunother. 2001 Mar-Apr;24(2):162-71.
10
CD40 ligand is essential for generation of specific cytotoxic T cell responses in RNA-pulsed dendritic cell immunotherapy.CD40配体在RNA脉冲树突状细胞免疫疗法中对于产生特异性细胞毒性T细胞反应至关重要。
Surgery. 2003 Aug;134(2):300-5. doi: 10.1067/msy.2003.240.

引用本文的文献

1
Autologous Human Dendritic Cells from XDR-TB Patients Polarize a Th1 Response Which Is Bactericidal to .来自广泛耐药结核病患者的自体人类树突状细胞极化出一种对……具有杀菌作用的Th1反应。
Microorganisms. 2025 Feb 5;13(2):345. doi: 10.3390/microorganisms13020345.
2
mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy.从实验室到临床的mRNA癌症疫苗:癌症免疫治疗的新时代。
Biomark Res. 2024 Dec 18;12(1):157. doi: 10.1186/s40364-024-00692-9.
3
mRNA as a medicine in nephrology: the future is now.信使核糖核酸作为肾脏病学中的一种药物:未来已来。
Clin Kidney J. 2023 Aug 17;16(12):2349-2356. doi: 10.1093/ckj/sfad196. eCollection 2023 Dec.
4
A review of the clinical experience with CMN-001, a tumor RNA loaded dendritic cell immunotherapy for the treatment of metastatic renal cell carcinoma.CMN-001 的临床经验综述,这是一种用于治疗转移性肾细胞癌的肿瘤 RNA 负载树突状细胞免疫疗法。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2220629. doi: 10.1080/21645515.2023.2220629. Epub 2023 Jun 30.
5
Predicting combinations of immunomodulators to enhance dendritic cell-based vaccination based on a hybrid experimental and computational platform.基于混合实验与计算平台预测免疫调节剂组合以增强基于树突状细胞的疫苗接种效果
Comput Struct Biotechnol J. 2020 Aug 8;18:2217-2227. doi: 10.1016/j.csbj.2020.08.001. eCollection 2020.
6
An autologous dendritic cell vaccine polarizes a Th-1 response which is tumoricidal to patient-derived breast cancer cells.自体树突状细胞疫苗可使 Th1 反应偏向于杀伤患者源性乳腺癌细胞。
Cancer Immunol Immunother. 2019 Jan;68(1):71-83. doi: 10.1007/s00262-018-2238-5. Epub 2018 Oct 3.
7
Immunogenicity of AGS-004 Dendritic Cell Therapy in Patients Treated During Acute HIV Infection.急性HIV感染期接受治疗的患者中AGS-004树突状细胞疗法的免疫原性
AIDS Res Hum Retroviruses. 2018 Jan;34(1):111-122. doi: 10.1089/aid.2017.0071. Epub 2017 Jun 21.
8
Recent Advances in the Medical Treatment of Recurrent or Metastatic Renal Cell Cancer.近年来复发性或转移性肾细胞癌的医学治疗进展。
Drugs. 2017 Jan;77(1):17-28. doi: 10.1007/s40265-016-0665-1.
9
Adenovirus co-expressing CD40 ligand and interleukin (IL)-2 contributes to maturation of dendritic cells and production of IL-12.共表达CD40配体和白细胞介素(IL)-2的腺病毒有助于树突状细胞的成熟和IL-12的产生。
Biomed Rep. 2016 Nov;5(5):567-573. doi: 10.3892/br.2016.773. Epub 2016 Oct 6.
10
Evolving Immunotherapy Approaches for Renal Cell Carcinoma.肾细胞癌不断发展的免疫治疗方法
Curr Oncol Rep. 2016 Sep;18(9):57. doi: 10.1007/s11912-016-0542-9.